货号：GS40353
Izenivetmab is an investigational, caninized monoclonal antibody that targets nerve growth factor (NGF). It is specifically developed for veterinary use, primarily in dogs. By binding to and inhibiting NGF, Izenivetmab blocks the pain signaling mediated through this key neurotrophin. It is designed as a long-acting, non-opioid analgesic for the management of chronic pain conditions in dogs, such as osteoarthritis pain, offering a novel mechanism distinct from traditional NSAIDs.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook，有助于交易顺利完成！
迈思生物